(Q40421375)

20 September 2017

1 reference

title

Clinical implications of insulin resistance syndromes (English)

1 reference

20 September 2017

1 reference

Davidson MB

1

1 reference

PubMed ID

7573099

20 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

American Journal of Medicine

20 September 2017

1 reference

20 September 2017

99

1 reference

20 September 2017

4

1 reference

20 September 2017

420-426

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Adiposity, fat distribution, and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin and Cardiovascular Disease: Paris Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Features of insulin-resistance syndrome in men from French Caribbean Islands. The Telecom Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

7 January 2021

Is insulin atherogenic?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Epidemiological data on hyperinsulinaemia and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Why can high insulin levels indicate a risk for coronary heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Why is insulin not a risk factor for coronary heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

The insulin resistance syndrome: the controversy is dead, long live the controversy!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Relationship between insulin resistance and risk factors for cardiovascular disease in Japanese non-insulin-dependent diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Serum insulin is a risk marker for coronary heart disease mortality in men but not in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Community diabetes care. A 10-year perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin resistance in hyperglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Prospective analysis of the insulin-resistance syndrome (syndrome X).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Isolated low HDL cholesterol. An insulin-resistant state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin and blood pressure in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin resistance in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Relationship between insulin resistance and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Insulin resistance in microvascular angina (syndrome X)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

Intensive insulin therapy and weight gain in IDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980191-0

10.1016/S0002-9343(99)80191-0

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7573099